Dr. Vladimir P. Torchilin, Ph.D., D.Sc., is a University Distinguished Professor of Pharmaceutical Sciences, and Director of the Center for Pharmaceutical Biotechnology and Nanomedicine, at Northeastern University, Boston, Massachusetts, USA. Dr. Torchilin’s research interests mainly include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy, etc. He has published more than 400 original papers, more than 150 reviews and book chapters, wrote and edited 12 books, and holds more than 40 patents. Dr. Torchilin has received more than $30mn from governmental and industrial sources in research funding. In 2011, Times Higher Education ranked him number 2 among the top world scientists in pharmacology for the period of 2000 to 2010.

Dr. Hwang is a professor of Graduate Institute of natural Products, Chang Gung University and a dean of College of Human Ecology, Chang Gung University of Science and Technology, Taiwan. Dr. Hwang obtained Ph.D. in pharmacology from National Taiwan University, Taiwan. His research interests include inflammopharmacology, innate immunity, phytopharmacology, and signal transduction. He has published more than 300 research papers and served as Editorial board member and reviewer for many professional journals.

Dr. Stefano Omboni graduated cum laude (with distinction would be better) in medicine at the University of Milan in 1988 and later specialized in cardiology at the same university in 1992. He is expert in the areas of blood pressure monitoring, telemonitoring, arterial hypertension, cardiovascular disease and telemedicine. His expertise also extends to clinical physiology and pharmacology. He is currently Director of the Italian Institute of Telemedicine, a research center located nearby Varese (Italy), which is dedicated to the research and development of new telemedicine solutions for the prevention and management of chronic diseases. The examples of such chronic diseases are hypertension, diabetes, asthma, heart failure, and for prevention of cardiovascular diseases.

Professor Yvonne Perrie is Professor in Drug Delivery at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Scotland. She has a BSc (First-Class Hons) in Pharmacy from Strathclyde University, and a PhD from the University of London under the supervision of Prof Gregoriadis. Yvonne’s research is multi-disciplinary and focused on the development of drug carrier systems for the delivery of drugs and vaccines. Yvonne is a Director-at-large for the Controlled Release Society. She is Editor-in-Chief of the Journal of Liposome Research and Pharmaceutics and Associate Editor for the Journal of Drug Targeting and the Journal of Pharmacy and Pharmacology.

Dr Ajay K Agrawal received his doctorate in Chemistry, and conducted his post- doctoral research in the Faculty of Medicine, University of Alberta, Canada and Molecular Cell Pathology, Royal Free Hospital, London on novel targeted cancer drug delivery therapeutics and imaging systems based on pegylation.

He has been in the board of directors of several biotech and pharma companies in UK, Europe and USA, including the development board of Buckingham Medical School, the first independent medical school in UK started recently, without any public money since Victorian times. Dr Agrawal has been in the editorial board of number of journals, published by Bentham Science Publishers. One of his invited review articles was cited in the “Current Awareness in Biomedicine: Drug Targeting Bulletin” after being scanned in over 2,500 journals.

She is interested towards the study of bioactive molecules from plant matrices. One other focus of her research includes the improvement of bioavailability and technological features of drugs and natural products extracts, by using conventional and innovative drug delivery systems. She has a deep knowledge in the analytics and pharmaceutical technology of herbal drugs, herbal drug preparations and herbal medicinal products. The purpose of its studies is to increase the solubility and/or the chemical stability of various natural plant extracts or compounds to improve their bioavailability profile and consequently the effectiveness.

Andreas Bernkop-Schnürch was educated in pharmacy at the Institute of Pharmacy (M.Sc.) and in microbiology and genetics at the Institute of Microbiology and Genetics (D.Sc.), University of Vienna, finishing his doctorate in 1994. In 2003 he was appointed to a chair in pharmaceutical technology at the University of Innsbruck, Austria. Dr. Bernkop-Schnürch is author of over 340 research articles and reviews as well as editor and (co-)author of several books. He is the founder of Mucobiomer GmbH (now part of the Croma-Pharma GmbH), Thiomatrix GmbH and Green River Polymers GmbH.

Claudia Carbone is Assistant Professor with Habilitation at the University of Catania, where she teaches Pharmaceutical Technology and Galenic Laboratory. She graduated in Pharmacy and got her PhD in Pharmaceutical Technology at University of Palermo. In 2017, she was visiting professor at the Faculty of Pharmacy of University of Coimbra, where she worked in collaboration with Prof Eliana Souto. Her research focus on advanced drug delivery systems to overcome biological barriers. She is interested in natural products and coating strategies. She is involved in the ophthalmic delivery research of the Research Centre for Ocular Nanotechnology in Catania.

MSc. and Ph.D. in Chemistry (Universidad de Buenos Aires, Argentina), Postdoc positions at Massachusetts Institute of Technology (1996-1998, Cambridge, USA) and Tufts University (Boston, US), later Adjunct Professor in the Dept Biomedical Eng., Tufts University (2001-2006, USA). Present positions: P.I. (Natl Res Council (CONICET, Argentina); Full Professor, Biotech Area, Dept of Chemistry, School of Sciences, National University of La Plata (UNLP, Argentina). Director of Nanobiomaterials Laboratory and Institute of Applied Biotechnology (CINDEFI, La Plata, Argentina). Scientific production: 5 patents, more than 120 papers and book chapters.

Dr. Roberta Cavalli, Full Professor of Pharmaceutical Technology, Dipartimento di Scienza e Tecnologia del Farmaco - Università degli Studi di Torino, has a multi-year experience in the design and development of either conventional pharmaceutical formulations or innovative nanotechnology-based drug delivery systems, as well as their in vitro and in vivo characterization. More recently, her interest moved to the design of novel polymer/lipid hybrid nanobubbles and nanodroplets, core-shell nanostructure filled with a gas or a liquid perfluorocarbon respectively. Dr. Roberta Cavalli played the role of Principal Investigator of a number of private and public multidisciplinary projects. She is the co-author of more than 170 full papers in peer-reviewed international journals with impact factor and more than 25 patents. Overall citations >5200, H index 40.

Christian Celia, Graduated in Pharmacy in 2004 at the University of Catanzaro “Magna Græcia”. In 2008, graduated as Pharm.D., and residence in Hospital Pharmacy at the University of Catanzaro “Magna Græcia”. In 2012, Prof. Celia received his Ph.D. in Pharmaceutical Science. From 2012 to 2017 Assistant Professor in Pharmaceutical Technology at the University of Chieti and Affiliated Scientist at Department of Nanomedicine, Houston Methodist Research Institute. Co-author of 61 papers, 1 proceeding paper edited in international peer-reviewed journals, and 2 Guest Editorial in international peer-reviewed journal, 100 Abstract conferences and communications, 2 book chapters, 1 Italian patent, 1 Poster Prize.

Mr. Chirag Patel is working in pharmaceutical company in Quality Assurance department. He has total 6 years of experience for development of Quality system in pharmaceutical company. He did his novel work by formulating phytosomes from herbal extract in his M. Pharma research work. Mr. Chirag Patel has published various Books, Research articles, Review articles and Short communications. His academic work includes 88 Publications (9 Books were published in Lambert Academic Publishing (LAP), Germany; 18 Research Articles, 56 Review Articles and 5 Short Communications were published in standard and reputed National and International Pharmacy Journals). He is an Editor -In- Chief as well as Manuscript Reviewer in Tyagi Pharmacy Association (TPA).

Dr. Dennis Christensen is leading the adjuvant research project at the Department of Infectious Disease Immunology, Statens Serum Institute and has for the last 14 years been working with pharmaceutical and immunological aspects of vaccine delivery systems. In this period he has obtained a unique research profile which bridges the gap between these two research fields. He’s research have in particular focused around the use of liposomes and emulsions as delivery systems for immunostimulators and vaccine-antigens and how physico-chemical properties of delivery systems and antigens as well as different routes of delivery and delivery devises can influence the immunological outcome. Dennis has played a major role in bringing the two adjuvants CAF01 and CAF09b into clinical trials.

Arik Dahan is an Associate Professor of Pharmaceutics and Biopharmaceutics at the Department of Clinical Pharmacology and the School of Pharmacy, Ben-Gurion University of the Negev in Beer-Sheva, Israel. He is also an Adjunct Professor of Pharmaceutical Sciences at the College of Pharmacy, University of Michigan. Dr. Dahan received his Ph.D. (2007) from the Hebrew University of Jerusalem. He was a Post-Doctoral Research Fellow at the University of Michigan (2007-2010) with Professor Gordon Amidon. Dr. Dahan's research interest is the integration of up-to-date molecular/cellular mechanistic investigations of drug disposition in the context of the human body.. He has published over 70 top-notch Journal papers.

Dr. Weiguo Dai is a Scientific Director in Drug Product Development at Johnson & Johnson. He is the Janssen Fellow and the Fellow of the American Association of Pharmaceutical Scientists (AAPS). Dr. Dai’s research and innovation have focused on design and development of novel formulations, delivery technologies/devices, and processes. His technology innovations have directly led to the launch of commercial drug products, and resulted in 50 peer-reviewed journal research articles. Dr. Dai earned his PhD degree from The Johns Hopkins University, and has over 20 years of industrial work experience in biotech/pharmaceutical companies, including Amgen, and Johnson and Johnson.

Prof. Desai directs the Therapeutic Microtechnology and Nanotechnology Laboratory at UC San Francisco and serves as Chair of the Department of Bioengineering and Therapeutic Sciences. Her research focuses on micro and nanofabrication techniques to create new devices for drug and cell delivery as well as biomaterials for cell and tissue regeneration. She has authored over 200 peer reviewed articles. Her work developing innovative drug delivery devices has garnered several academic and industry awards. She has has mentored many post-docs and PhD students who have gone on to successful academic and industry positions. Prof. Desai was elected to the National Academy of Medicine.

Dr. Dorkoosh has received his PhD in pharmaceutics and biopharmaceutics from Leiden University in the Netherlands in 2002. He followed an international training on intellectual property and management of innovation at World Intellectual Property Organization (WIPO) in Geneva, Switzerland in 2005. He got also his Diploma in management from Chartered Management Institute of London, UK in 2009. He is currently a professor at Tehran University of Medical Sciences. He is also the head of Patent office of Tehran University of Medical Sciences. Dr. Dorkoosh published more than 110 research articles and held 10 patents and patent applications.

Camilla Foged is leading the research group named Vaccine Design and Delivery at Department of Pharmacy, University of Copenhagen, Denmark.She has an MSc in Biochemistry from University of Copenhagen (1998), and she attained her PhD in Pharmaceutics in 2003from The Danish University of Pharmaceutical Sciences. In 2018,she was appointedas Full Professor in vaccine design and delivery at the University of Copenhagen. Prof. Foged has published more than 90 research articles, reviews and book chapters.

Franz Gabor received his PhD from the University of Vienna for interdisciplinary work for development of monoclonal antibodies in cooperation with the general hospital Vienna and the Institute of Biochemistry. His work on targeted drug delivery for treatment of Ewing’s sarcoma was awarded by the “Herba-award” and followed by habilitation in pharmaceutical technology at the Department of Pharmaceutical Technology & Biopharmaceutics in Vienna in 1998. Franz Gabor is author of more than 120 research articles and reviews, his research interests focus on lectin-mediated drug delivery for therapy of bladder diseases and drug delivery to the inner ear.

Prof. Antonio Gloria is a Researcher at the National Research Council of Italy and Professor at different universities. He isa Scientific Advisory Board Member of the FraunhoferInternational Joint LaboratoryIdeas –University of Naples “Federico II”. He is a Member of the European Society for Biomaterials, the ACS and a Full Member of the ANS. He was awarded and appointed as “Future Leader” in Science and Technology (“Dialogue between Nobel Laureates and Future Leaders,” STS Forum, October 2015, Kyoto, Japan). His main research interests include Additive Manufacturing, Reverse Engineering, Design, Modeling and Simulation, Materials Science and Technology, Biomechanics, Biomaterials, Tissue Engineering.

Dr Gul has expertise in drug discovery with a record of accomplishment in academia (University of London), industry (GlaxoSmithKline Pharmaceuticals) and as an Adjunct Lecturer. He is a Key Opinion Leader in drug discovery and scientific co-founder of a biotech company (Transcriptogen Ltd). He has co-ordinated work packages in numerous assay development, screening, Hit-finding and Hit-to-Lead projects, is a co-author of numerous peer-reviewed papers, chapters, publically available opinion pieces and the Enzyme Assays: Essential Data handbook and has organised drug discovery workshops since 2011 across the globe resulting in the training of 470 scientists.

Dr. Bhuvanesh Gupta is the Professor of Polymers at Indian Institute of Technology, New Delhi and is the President of three international bodies; Asian Polymer Association, Society of Biomaterials Artificial Organs India (Delhi), and Indo-Italian Forum on Biomaterials & Tissue Engineering. Dr. Gupta did his PhD from IIT Delhi and spent a couple of years as post-doc in Paris. Subsequently, Dr. Gupta worked for eight years in France, Sweden and Switzerland under different capacities in several laboratories. Dr. Gupta initiated research career in the field of polymer functionalisation, biomaterials and tissue engineering and worked in collaboration with University of Uppsala, Sweden and INSERM Paris, France.

Vitaliy Khutoryanskiy is Professor of Formulation Science (since 2014), having previously been Associate Professor in Pharmaceutical Materials (2010-2014) and Lecturer in Pharmaceutics (2005-2010) at the University of Reading, UK. Prof Khutoryanskiy has researched broadly in the area of materials for pharmaceutical and biomedical applications, with a particular emphasis on drug delivery, mucoadhesive materials, hydrogels, and stimuli-responsive polymers. He has published over 120 original research articles, 14 reviews, and edited 2 books.

Dr. R. V. Kulkarni obtained his Ph.D degree in Pharmaceutical Sciences from Jadavpur University, Kolkata, India. Presently he is working as Professor and Vice-Principal at BLDEA’s SSM College of Pharmacy & Research Centre, BLDE University campus, Vijayapur, India. His area of research comprises novel drug delivery systems including hydrogel based oral and transdermal drug delivery systems. He published more than 80 papers in reputed journals and filed one patent. He is a recipient of “Award for Best Research Paper” from Government of Karnataka, India. He is an editorial board member of various journals including Bentham Science Journal “Drug Delivery Letters” and “BLDE University Journal of Health Sciences”.

Dr. Yung-Chih Kuo is a professor at National Chung Cheng University. His research interests are focused on biomaterials, nanomedicine, tissue engineering, blood–brain barrier, cancer therapy, nerve regeneration, spinal cord injury and stroke treatment, and Alzheimer’s and Parkinson’s disease therapy. He has authored over 140 SCI journal papers. He is a fellow of Royal Society of Chemistry (UK) and an honor member of Phi Tau Phi Society. He won Best Paper Award in 2016 and 2008, Prof. Tsai-Teh Lai Award in 2015, Special and Talented Scholar Award in 2013-5, Outstanding Research Award in 2013, and Young Scholar Award in 2003.

Dr. Lamprecht is currently Professor for Pharmaceutics at the University of Bonn (Germany). He received his Ph.D from Saarland University (Germany) and after postdoctoral fellowships in France and Japan, he was previously appointed at the Universities of Nancy and Besancon (France). From 2007 to 2012 he was external expert at the French Health Products Safety Agency and is currently serving in the scientific advisory board of the Federal Institute for Drugs and Medical Devices in Germany. He has published more than 150 research articles and received several awards. He is an Alexander-von-Humboldt Fellow and was nominated as member of “Institut Universitaire de France” in 2007.

Dr. Lane obtained a doctorate (Ph.D.) in Pharmaceutical Science from Trinity College, Dublin, Ireland. Dr. Lane also holds qualifications in statistics and project management. Currently Dr. Lane is a Senior Lecturer and Director of the Skin and Buccal Research Centre at the UCL School of Pharmacy. She has published more than 130 scientific publications and is the Chairperson of Skin Forum, a multidisciplinary network of scientists with a common interest in skin. Dr. Lane is currently the Editor-in-Chief of the International Journal of Cosmetic Science and serves on the editorial boards of Current Drug Delivery, published by Bentham Science Publishers, Cosmetics, the International Journal of Pharmaceutics, Journal of Biophysical Chemistry, Journal of Drug Targeting, Journal of Microencapsulation, Journal of Pharmaceutical Sciences and Phytotherapy Research.

Dr. Olivia Merkel is a Professor of Drug Delivery in the Department of Pharmacy at LMU Munich in Germany and Adjunct Faculty in the Department of Pharmaceutical Sciences at Wayne State University. From 2011 until 2016 she was an Assistant Professor of Pharmaceutical Sciences and an Associate Faculty Member of Oncology at Wayne State University, Detroit, MI, USA, where she is also a Scientific Member of the Molecular Therapeutics Program and Faculty in the Cancer Biology Graduate Program at Barbara Ann Karmanos Cancer. In 2004 she completed her university degree in Pharmacy at Philipps-Universität Marburg, Germany and became a Registered Pharmacist in 2005. In 2006, she received a MS in Pharmaceutical Technology from Martin-Luther-Universität Halle-Wittenberg, and graduated with a PhD in Pharmaceutical Technology from Philipps-Universität Marburg, Germany, in 2009.

Dr. Rouslan I. Moustafine is Associate Professor of Pharmacy at Kazan State Medical University (KSMU) Tatarstan, Russian Federation. He is the Head of the Department of Pharmaceutical, Analytical and Toxicological Chemistry since 2003, the Dean of Faculty of Pharmaceutical Sciences since 2009 and the member of the academic senate of KSMU. He earned his Ph.D. in Pharmaceutical Technology from I.Sechenov’s Moscow State Medical Academy in 1991. His area of specialization is the development of interpolyelectrolyte complexes (IPEC) with Eudragits® and other pharmaceutical polymers. Dr. Moustafine has published over 50 peer-reviewed journal articles, reviews and two book chapters in the fields of dissolution testing of oral drug delivery systems.

Dr. Masoud Mozafari earned his Ph. D. degree with honors in Biomedical Engineering-Biomaterials from Amirkabir University of Technology (Tehran Polytechnic), 2013. He then joined Oklahoma State University and Pennsylvania State University as a research associate and research visiting scholar. He has published extensively in the area of biomedical engineering, and as of July 2017, he has been cited more than 1800 times and has an h-index of 24. He has received several awards including “Top 10 National Outstanding Scientific Authors” (2012). He is currently an assistant professor and head of “Bioengineering Research Group” in Nanotechnology and Advanced Materials Department, Materials and Energy Research Center (MERC).

Dr. Mangal S. Nagarsenker, currently Professor and Head, Dept. of Pharmaceutics, Bombay College of Pharmacy, Mumbai, has 34 years of research experience in design and formulation of nanosystems and controlled release systems for oral, parenteral, topical, pulmonary and ophthalmic routes and gene delivery. A gold medallist in graduate pharmacy school, she further pursued her PhD in Pharmaceutical Sciences from Mumbai University. She has reviewed several articles in different national and international journals, is a member of the editorial board of Indian Journal of Pharmaceutical Sciences and has authored around 100 research articles (national and international), 6 review articles, 3 book chapters and 2 books. Her research group has more than 100 research papers presented at various national and international conferences to her credit and has been granted 2 Indian patents and 3 trademarks.

Dr. das Neves received his PhD degree in Pharmaceutical Sciences from the University of Porto, Portugal. He is currently a researcher at i3S - Institute for Research and Innovation in Health, University of Porto. His research topics include drug nanocarriers, mucosal drug delivery and biomedical materials. He is the author of 68 peer-reviewed articles, 10 book chapters and 50 presentations at scientific meetings. Dr. das Neves is also the co-Editor of four scientific books and Editorial Board member of several international journals.

Rosario Pignatello is Full Professor of Pharmaceutical Technology and Legislation at the University of Catania, Italy. He is member of the Scientific Committee of the Inter-University Consortium TEFACO Innova (Parma, Italy).

He has nearly 30 years of experience in the research and development of innovative formulations for the controlled release and targeting of bioactive molecules, through chemical approaches as well as colloidal (nano) drug carriers, aimed to treat different disorders. In particular, Prof. Pignatello works actively in the field of ocular drug delivery, leading the scientific committee of the Research Centre for Ocular Nanotechnology in Catania (NANO-i).

Prof. Pignatello has authored about 135 papers and edited a series of textbooks on biomaterials and their application in medicine (InTech Publisher).

Professor Des Richardson holds the Chair of Cancer Cell Biology at the University of Sydney, Australia, and is a National Health and Medical Research Council (NHMRC) of Australia Senior Principal Research Fellow. He has published more than 405 articles, reviews, patents, chapters etc., over his career with more than 93% as first, senior or corresponding author (H-index: 79; more than 23,735 citations over entire career; with more than 14,806 citations over the past 5 years and H-index: 57 over past 5 years: Google Scholar Accessed 29 Nov, 2017). He is Executive Editor of BBA-General Subjects and has served on the Editorial Boards of more than 40 international journals, including J. Biol. Chem., Antioxidants Redox Signaling, Biochem. J., BBA-Mol Cell Res, Mol. Pharmacol., Pharmacol. Res., etc.

Dr. Imran Saleem is a Reader in Nanomedicne within the School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, UK. He has been working in and has published numerous papers in the area of pulmonary drug delivery since 2006. His research is aimed at developing novel delivery systems for targeting therapeutic agents to their site of action, with particular emphasis on lung diseases via dry powder pulmonary delivery. He has over 10 years’ experience in the area of nanoparticle formulation and drug delivery systems, and has published extensively (80+) in peer-reviewed journals, conference abstracts and book chapters.

Dr. Santos obtained a doctorate (D.Sc.) in Chemical Engineering from the Helsinki University of Technology, Helsinki, Finland. Currently Dr. Santos is an Adjunct Professor in Pharmaceutical Nanotechnology at the University of Helsinki, Finland. He has published more than 150 scientific publications. Dr. Santos serves as Editor and is in the Editorial Board of several international journals.

Dr. Bruno Sarmento graduated in Pharmaceutical Sciences at the University of Porto in 2002 and completed a PhD in Pharmaceutical Nanotechnology at UP in 2007, in collaboration with Queen’s University (CA), University of Copenhagen (DK) and University of Santiago de Compostela (ES). From 2007 to 2012 he held a Post-Doc position at University of Porto, in collaboration with the University of Copenhagen, investigating insulin intestinal absorption mechanisms using in vitro models. In 2008 he was appointed Assistant Professor at IUCS. He was appointed as Assistant Researched at Institute of Innovation and Research in Health/Institute of Biomedical Engineering (i3S/INEB) in 2016.

Hugh D. C. Smyth is the Hamm Endowed Faculty Fellow and Associate Professor of Pharmaceutics with Tenure, College of Pharmacy, The University of Texas at Austin. He is also an Adjunct Associate Scientist at the Lovelace Respiratory Research Institute, Albuquerque, New Mexico and Chief Scientist at Respira Therapeutics. He has been a faculty member at the University of North Carolina, Chapel Hill and at the University of New Mexico. He was the American Association of Pharmaceutical Scientists (AAPS) New Investigator award winner for Pharmaceutics and Pharmaceutical Technologies in 2007.

Prof. Alejandro Sosnik received his Pharmacy degree from the Faculty of Pharmacy and Biochemistry of the University of Buenos Aires in 1994. After two years as junior research scholar of the University of Buenos Aires in the field of organic chemistry (1993-5). In early 1997, he moved to Israel where after obtaining the pharmacist license, he continued his graduate studies, receiving Ph.D. in applied chemistry (polymeric biomaterials) from the Casali Institute of Applied Chemistry (The Hebrew University of Jerusalem, Israel, 2003) under the supervision of Prof. Daniel Cohn. In 2003-6, Prof. Sosnik spent a postdoctoral in the laboratory of Professor Michael Sefton (Institute of Chemical Engineering and Applied Chemistry/Institute of Biomaterials and Biomedical Engineering, University of Toronto, Canada) working in the development of hybrid matrices for cell culture and tissue engineering. Between 2006 and 2013, Prof. Sosnik was Assistant Professor of Pharmaceutical Technology at the Faculty of Pharmacy and Biochemistry (University of Buenos Aires) and Investigator of the National Science Research Council of Argentina.

Since November 2005, Dr. Giovanni Tosi is researcher in the scientific field of Pharmaceutical Technology at the University of Modena and Reggio Emilia. Since 2015, he is associate professor in the same field. He got his PhD in Pharmaceutical Sciences in 2005 at the University of Modena and Reggio Emilia, Italy. He is now Coordinator of "Applied Technology" curricula for the PhD school in Health Products, member of Instruments Commission of Dep. Pharm. Sci., Contact Person ILO of Dep. Pharm. Sci, Research products, Representative of the Dep. Pharm. Sci. in the Central Board of Animal House of University of Modena and Reggio Emilia. He is author or co-author of more than 90 publications in international journals (of which 5 are reviews and 3 are book chapters) and gave over 200 presentations (invited speaker, oral presentations and posters) in international and national congresses.

Dr. Ijeoma Uchegbu is a Professor of Pharmaceutical Nanoscience at the UCL School of Pharmacy, University College London (UCL), UCL’s Pro-Vice Provost for Africa and The Middle East and Chief Scientific Officer of Nanomerics Ltd. Nanomerics is a UCL spin out company, which was founded by Ijeoma and Andreas G. Schätzlein. She has been awarded various prizes for her work, notably the UK Department for Business Innovation Skills’ Women of Outstanding Achievement in Science Engineering and Technology award, the Royal Pharmaceutical Society’s Pharmaceutical Scientist of the Year 2012 and the Academy of Pharmaceutical Sciences Innovative Science Award 2016. She is the editor of three books, a named inventor on 11 granted patents and has authored over 120 peer reviewed journal articles and book chapters.

Professor Dr Wong Tin Wui is presently the lecturer and researcher at the Non-Destructive Biomedical and Pharmaceutical Research Centre, iPROMISE, UniversitiTeknologi MARA. His research areas are primarily focused on particle/scaffold design for oral, transdermal and pulmonary drug delivery, development of novel non-destructive pharmaceutical analyzers, as well as, design of pharmaceutical processors for innovative dosage form manufacture.

Dr. Yallapu (Ph.D.) is an Assistant Professor of Pharmaceutical Sciences from the University ofTennessee Health Science Center, Memphis, USA. Dr. Yallapu is a Gold Medalist, NIH-Career Awardee, and Young Investigator in Nanotechnology. He has published more than 105 scientific publications/reviews/book chapters and his work has been presented more than 70 abstracts/posters/podium in scientific meetings. He is a named inventor of a U.S patent. His work has been cited more than 6000 times in scientific literature with an h-index 40 and i10-index 77.

Dr. Paul Young holds the Chair of Commercialisation in the Faculty of Medicine and Health at the University of Sydney, Australia and is Deputy Executive Director & Professor of Respiratory Technology at the Woolcock Institute of Medical Research. He has made a significant contribution in the field of inhalation science and has published 200 peer reviewed articles in international journal, 5 patents, 15 book chapters and in excess of 100 conference proceedings. He is a Chartered Chemist of the Australian Royal Society of Chemistry. He collaborates with both academia and industry on an international level and has attracted more than AUD 18 million dollars in funding within the area of inhalation medicine.

Dr. Yuksel obtained a doctorate (Ph. D.) in Pharmaceutical Technology from Faculty of Pharmacy, Ankara University, Turkey. She worked as a postdoc fellow in Industrial Pharmacy Program in the University of Cincinnati Faculty of Pharmacy for one year. Currently, Dr. Yuksel is a Professor at the Departmant of Pharmaceutical Technology in Ankara University Faculty of Pharmacy. She has about 45 scientific articles. She is editorial board member of the journals named “Current Drug Delivery” and “The Scientific World Journal”. She also serves as a member of the advisory committee for generic drug products in Turkey Drug and Medicinal Device Agency.

Dr. Hongwei Zhang is Assistant Professor at the School of Pharmacy - Boston, MCPHS University. Dr. Zhang obtained his Ph.D. degree in Pharmaceutics from Sichuan University and received postdoctoral training in the Gene Therapy Center at the University of Massachusetts Medical School. Dr. Zhang is an internationally recognized expert in nanomedicine and gene transfer. He has received multiple awards, including the Innovation in Biotechnology Award from American Association of Pharmaceutical Scientists and the Postdoctoral Fellowship Award from the American Heart Association. Dr. Zhang has authored nearly 50 manuscripts and 3 patents.

Dr. Mire Zloh is a Professor of Medicinal Chemistry at the University of Hertfordshire. He was awarded an MSc in Physical Chemistry by University of Belgrade and earned a PhD in Chemistry at the University of London. Previously he was a Senior Lecturer and Director of the Centre for Structural Chemistry at the UCL School of Pharmacy. Dr. Mire Zloh has authored more 100 scientific publications and reviews. His research interests include drug design, structural chemistry and computer aided design of formulations, including a rational development of dendrimers as drug delivery systems and as therapeutics.